Modafinil vs Lisdexamfetamine
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Modafinil (Provigil) and lisdexamfetamine (Vyvanse) are both used to promote wakefulness and improve focus, but they are approved for different conditions and carry different regulatory classifications. Modafinil is FDA-approved for narcolepsy, obstructive sleep apnea-related sleepiness, and shift work disorder. Lisdexamfetamine is approved for ADHD and binge eating disorder.
Modafinil is a Schedule IV controlled substance (lower abuse potential), while lisdexamfetamine is Schedule II (higher abuse potential). This regulatory distinction reflects differences in their pharmacology and influences prescribing patterns.
Modafinil vs Lisdexamfetamine: Side-by-side comparison
| Category | Modafinil | Lisdexamfetamine |
|---|---|---|
| FDA-Approved For | Narcolepsy, sleep apnea sleepiness, shift work | ADHD, binge eating disorder |
| DEA Schedule | Schedule IV | Schedule II |
| Mechanism | Wakefulness-promoting (exact mechanism unclear) | Prodrug amphetamine (dopamine/norepinephrine) |
| Duration | 12-15 hours | 10-14 hours |
| Appetite Suppression | Mild | Significant |
| Cardiovascular Effects | Minimal | More pronounced |
| Abuse Potential | Low | Moderate (reduced by prodrug design) |
Efficacy: How well does each drug work?
For narcolepsy and excessive daytime sleepiness, modafinil is the standard first-line treatment. Clinical trials show it significantly improves wakefulness, reduces daytime sleepiness, and improves functional outcomes. It does not treat cataplexy (sudden muscle weakness), which may require additional medication.
Lisdexamfetamine is not FDA-approved for narcolepsy or sleepiness disorders, though amphetamines have historically been used for narcolepsy. For ADHD, lisdexamfetamine is highly effective, with response rates of 70-80% and rapid onset of benefit.
Modafinil is sometimes used off-label for ADHD, fatigue in multiple sclerosis, and cognitive enhancement, though evidence for these uses is weaker than for approved indications.
Side effects comparison
Modafinil's common side effects include headache, nausea, anxiety, and insomnia. Serious but rare side effects include Stevens-Johnson syndrome (skin reaction) and multi-organ hypersensitivity. Modafinil has a lower cardiovascular impact than amphetamines — it causes less tachycardia and blood pressure elevation.
Lisdexamfetamine's common side effects include decreased appetite, insomnia, dry mouth, increased heart rate, and anxiety. As a Schedule II stimulant, it carries risks of dependence, tolerance, and cardiovascular effects. Weight loss from appetite suppression can be significant.
Modafinil can reduce the effectiveness of hormonal contraceptives (birth control pills), which is an important consideration for women of childbearing age.
Cost comparison
Brand-name Provigil has been expensive, but generic modafinil is now available at $30-$80 per month. Generic lisdexamfetamine became available in 2023, bringing costs down from the $300+ range to approximately $50-$150 per month depending on pharmacy and dose.
Insurance coverage varies. Modafinil may require prior authorization for non-narcolepsy uses. Lisdexamfetamine coverage for ADHD is generally good but may require step therapy.
Convenience and dosing
Both medications are taken once daily in the morning. Modafinil's effects last approximately 12-15 hours, while lisdexamfetamine provides 10-14 hours of coverage. Neither requires titration based on blood tests.
Modafinil's lower scheduling (Schedule IV) means easier prescription refills in most states compared to lisdexamfetamine (Schedule II), which may require new written prescriptions monthly.
Which is right for you?
If you have narcolepsy or excessive sleepiness from sleep apnea, modafinil is the appropriate first-line choice. It provides wakefulness promotion with a lower side effect burden and less abuse potential than traditional stimulants.
If you have ADHD, lisdexamfetamine is the evidence-based option with strong clinical trial support. While modafinil is sometimes used off-label for ADHD, the evidence base is not as strong.
The choice may also depend on your cardiovascular health, history of substance use, and tolerance for appetite suppression and weight loss. Discuss your specific needs with your prescriber.
Frequently asked questions
References
- [Observational] Provigil (modafinil) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037lbl.pdf Accessed 2026-03-01.
- [Observational] Vyvanse (lisdexamfetamine) FDA Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021977s045lbl.pdf Accessed 2026-03-01.
- [Observational] Modafinil for Narcolepsy - Cochrane Review https://pubmed.ncbi.nlm.nih.gov/12804434/ Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: